MedPath

Effect of oxytocin infusion on reducing operative blood loss during abdominal myomectomy

Not Applicable
Conditions
Bleeding during abdominal myomectomy.
Leiomyoma of uterus
Registration Number
IRCT201211217013N3
Lead Sponsor
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

Including criteria: Women undergoing abdominal myomectomy; over 35 years age
Excluding criteria: Patients candidate for hysteroscopic myomectomy; Patients with preoperative GnRH agonist consumption; Patients with history of cardiopulmonary disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of bleeding. Timepoint: During myomectomy. Method of measurement: Count sponges and the amount of blood collected in the suction device - according to ml.
Secondary Outcome Measures
NameTimeMethod
The amount of blood transfusion. Timepoint: Intra and postoperative. Method of measurement: Observation, Physical examination- Blood unit according to ml.;Hb and HcT values. Timepoint: Prior to operation and 24 h after operation. Method of measurement: Elyza method-CBC[ Hb(g/dl), HcT(%)}.
© Copyright 2025. All Rights Reserved by MedPath